Skip to main content
Search

VIT Bhopal University

2 related articles

Subscribe to updates
  1. Parkinson's diagnosis stops leaning on one modality: voice, gait, imaging and clinical data share a dynamic graph, holding 95.8% zero-shot on an external European cohort

    Parkinson's disease diagnosis still rests on symptoms and expert assessment, while multimodal clinical data are heterogeneous, labels are scarce, and deep models rarely report calibrated confidence. NeuroQ-MGST encodes voice, gait, neuroimaging and clinical variables with spiking neural networks, aligns them through self-supervised contrastive and masked reconstruction objectives, reasons over a dynamically rebuilt heterogeneous graph with a hierarchical graph transformer, and adds quantum-inspired variational refinement plus Monte Carlo dropout uncertainty. On the PMMD 2.0 test set it reaches 98.7% accuracy and 0.989 AUC-ROC, and 95.8% zero-shot accuracy on an external European cohort without fine-tuning.

  2. medRxiv

    PCOS screening stops hiding behind one accuracy number: rarest subtype recall climbs from 75% to 87.5%

    Machine learning screening for polycystic ovary syndrome has long reported a single binary accuracy, hiding differences between clinical subtypes. On a public dataset of 541 patients, a tuned random forest reached per-subtype accuracy ranging from 75.0% on the rarest subtype to 97.8% on the most common, a 22.8-point spread that stayed at 23.3 points after removing the seven variables used to define subtypes. A multi-task neural network with random-forest feature ranking and genetic-algorithm tuning predicts the binary label and the subtype together, holding 90.2% binary accuracy while lifting rarest-subtype recall from 75.0% to 87.5% and unclassified-case recall from the multi-class model's 31.5% to 79.6%.

You’re all caught up